Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Upplands Vasby – page 23

847 clinical trials in Upplands Vasby, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Upplands Vasby at a glance
847
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

847 trials in Upplands Vasby

Open in trial search

Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

VEXAS syndrome

Recruiting

Study of Azacitidine Treatment in Patients with VEXAS Syndrome

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Region Hovedstaden

Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study of Inebilizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Inebilizumab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Study on Propranolol and Pembrolizumab for Patients with Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Region Hovedstaden

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Karolinska University Hospital

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Merck Sharp & Dohme LLC

Paedophilia

Recruiting

Study on Fluoxetine and E-therapy for Men Seeking Help with Pedophilic Disorder

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Fluoxetine
  • Sponsor:Karolinska University Hospital

Study on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Region Oestergoetland

Pain in jaw

Recruiting

Study on the Effects of Botulinum Toxin in Patients with Jaw Muscle Pain (TMD)

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Sponsor:Karolinska Institutet

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Upplands Vasby

What the registry says about research in the country

01 Neurology

Clinical research focusing on migraine treatment, evaluating new therapeutic approaches for acute attacks. These trials aim to assess the effectiveness of novel medications in managing migraine symptoms and improving patient outcomes.

  • Acute migraine treatment
  • Pain management
  • Neurological disorders

Studies include double-blind, placebo-controlled methodologies to ensure reliable results.

02 Infectious Diseases

Ongoing research into Herpes Zoster prevention, with studies examining long-term vaccine efficacy and immune response in older adults. These trials focus on protecting vulnerable populations against shingles.

  • Vaccine development
  • Immune response
  • Preventive medicine

Research emphasizes long-term safety monitoring and effectiveness evaluation.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.